Cholinesterases and the basal lamina at vertebrate neuromuscular junctions

Current Opinion in Pharmacology

Volumn 9, Issue 3, 2009, Pages 316-325

  Massoulié, Jean ^a   Millard, Charles B ^b  

^a ECOLE NORMALE SUPÉRIEURE   (France)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; CHOLINESTERASE; LAMININ; PERLECAN; PROTEOHEPARAN SULFATE;

BASEMENT MEMBRANE; COLLAGEN SYNTHESIS; CONGENITAL MYASTHENIC SYNDROME; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; MUSCLE DEVELOPMENT; MUSCLE INNERVATION; MUSCULAR DYSTROPHY; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SCHWARTZ JAMPEL SYNDROME; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS;

ACETYLCHOLINESTERASE; ANIMALS; BASEMENT MEMBRANE; COLLAGEN; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MUSCLE PROTEINS; NEUROMUSCULAR JUNCTION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; VERTEBRATES;

EID: 65749096071     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.04.004     Document Type: Review

References (72)

1. •,9], will provide reader with strong background in the basic structure function of the BL.
2. Lichtman J.W., and Sanes J.R. Watching the neuromuscular junction. J Neurocytol 32 (2003) 767-775. Key reference for emerging methods to study NMJ assembly and component interactions. Transgenic mice in which motor axons are fluorescently labeled, coupled with selective post-synaptic stains, provide a new way to image NMJs in vivo over several weeks.
3. Sanes J.R. The basement membrane/basal lamina of skeletal muscle. J Biol Chem 278 (2003) 12601-12604. The specificity of synaptic vs. extrasynaptic BL in mammalian muscle.
4. Burden S.J., Sargent P.B., and McMahan U.J. Acetylcholine receptors in regenerating muscle accumulate at original synaptic sites in the absence of the nerve. J Cell Biol 82 (1979) 412-425
5. Patton B.L. Basal lamina and the organization of neuromuscular synapses. J. Neurocytol. 32 (2003) 883-903. The distribution of BL components in extrasynaptic regions, primary cleft and secondary folds at the NMJ.
6. Sketelj J., and Brzin M. Asymmetric molecular forms of acetylcholinesterase in mammalian skeletal muscles. J Neurosci Res 14 (1985) 95-103
7. Iozzo R.V. Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol 6 (2005) 646-656. An authoritative review on the molecular structure of perlecan.
8. Massoulié J. The origin of the molecular diversity and functional anchoring of cholinesterases. NeuroSignals 11 (2002) 130-143. Key reference for understanding ColQ and the multiple molecular forms of AChE accounting for the biological distribution and function of the enzyme.
9. Nishimune H., Valdez G., Jarad G., Moulson C.L., Müller U., Miner J.H., and Sanes J.R. Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. J Cell Biol 182 (2008) 1201-1215
10. Fox M.A., Ho M.S., Smyth N., and Sanes J.R. A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. Neural Dev 3 (2008) 24
11. Nishimune H., Sanes J.R., and Carlson S.S. A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals. Nature 432 (2004) 580-587
12. Ichikawa N., Kasai S., Suzuki N., Nishi N., Oishi S., Fujii N., Kadoya Y., Hatori K., Mizuno Y., Nomizu M., et al. Identification of neurite outgrowth active sites on the laminin alpha4 chain G domain. Biochemistry 44 (2005) 5755-5762
13. Talts J.F., Andac Z., Gohring W., Brancaccio A., and Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J 18 (1999) 863-870
14. Patton B.L., Cunningham J.M., Thyboll J., Kortesmaa J., Westerblad H., Edström L., Tryggvason K., and Sanes J.R. Properly formed but improperly localized synaptic specializations in the absence of laminin 4. Nat Neurosci 4 (2001) 597-604
15. Bezakova G., and Ruegg M.A. New insights into the roles of agrin. Nat Rev Mol Cell Biol 4 (2003) 295-308. Structural, functional interactions of agrin splice variants.
16. Zhou H., Glass D.J., Yancopoulos G.D., and Sanes J.R. Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializations. J Cell Biol 146 (1999) 1133-1146
17. Kim N., Stiegler A.L., Cameron T.O., Hallck P.T., Gomez A.M., Huang J.H., Hubbard S.R., Dustin M.L., and Burden S.J. Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 135 (2008) 334-342
18. Zhang B., Luo S., Wang Q., Suzuki T., Xiong W.C., and Mei L. LRP4 serves as a coreceptor of agrin. Neuron 60 (2008) 285-297
19. Gautam M., DeChiara T.M., Glass D.J., Yancopoulos G.D., and Sanes J.R. Distinct phenotypes of mutant mice lacking agrin, MuSK, or rapsyn. Dev Brain Res 114 (1999) 171-178
20. Lin S., Maj M., Bezakova G., Magyar J.P., Brenner H.R., and Ruegg M.A. Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice. Proc Natl Acad Sci U S A 105 (2008) 11406-11411
21. Jaworski A., and Burden S.J. Neuromuscular synapse formation in mice lacking motor neuron- and skeletal muscle-derived neuregulin-1. J Neurosci 26 (2006) 655-661. Evidence that neuregulin-1 is not required for the synaptic expression of AChRs at NMJs.
22. Kummer T.T., Misgeld T., and Sanes J.R. Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr Opin Neurobiol 16 (2006) 74-82. The current view on the essential role of agrin in the induction of NMJs.
23. Whitelock J.M., Melrose J., and Iozzo R.V. Diverse cell signaling events modulated by perlecan. Biochemistry 47 (2008) 11174-11183
24. Peng H.B., Xie H., Rossi S.G., and Rotundo R.L. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 145 (1999) 911-921
25. Arikawa-Hirasawa E., Rossi S.G., Rotundo R.L., and Yamada Y. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. Nat Neurosci 5 (2002) 119-123. The accumulation of ColQ-AChE at NMJs is abolished in the absence of perlecan.
26. Bix G., Fu J., Gonzalez E.M., Macro L., Barker A., Campbell S., Zutter M.M., Santoro S.A., Kim J.K., Höök M., et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol 166 (2004) 97-109
27. Jacobson C., Côté P.D., Rossi S.G., Rotundo R.L., and Carbonetto S. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 152 (2001) 435-450
28. McDearmon E.L., Combs A.C., and Ervasti J.M. Core 1 glycans on alpha-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding. J Biol Chem 278 (2003) 44868-44873
29. Massoulié J., Perrier N., Noureddine H., Liang D., and Bon S. Old and new questions about cholinesterases. Chem Biol Int 175 (2008) 30-44. Current questions regarding cholinesterase structure, interactions, and functions.
30. Krejci E., Coussen F., Duval N., Chatel J.M., Legay C., Puype M., Vandekerckhove J., Cartaud J., Bon S., and Massoulié J. Primary structure of a collagenic tail peptide of Torpedo acetylcholinesterase: co-expression with catalytic subunit induces the production of collagen-tailed forms in transfected cells. EMBO J 10 (1991) 1285-1293
31. Krejci E., Thomine S., Boschetti N., Legay C., Sketelj J., and Massoulié J. The mammalian gene of acetylcholinesterase-associated collagen. J Biol Chem 272 (1997) 22840-22847. Description of the mammalian ColQ gene.
32. Perrier A.L., Massoulié J., and Krejci E. PRiMA, the membrane anchor of acetylcholinesterase in brain. Neuron 33 (2002) 275-285
33. Bon S., Coussen F., and Massoulié J. Quaternary associations of acetylcholinesterase. II. The polyproline attachment domain of the collagen tail. J Biol Chem 272 (1997) 3016-3021
34. Dvir H., Harel M., Bon S., Liu W.Q., Vidal M., Garbay C., Sussman J.L., Massoulié J., and Silman I. The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix. EMBO J 23 (2004) 4394-4405. Crystallographic analysis of the interaction among four C-terminal T-peptides of AChE and a PRAD peptide from ColQ; deduced organization of an AChE tetramer associated with one strand of the ColQ collagen.
35. Li H., Schopfer L.M., Masson P., and Lockridge O. Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers. Biochem J 411 (2008) 425-432
36. Feng G., Krejci E., Molgo J., Cunningham J.M., Massoulié J., and Sanes J.R. Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J Cell Biol 144 (1999) 1349-1360. AChE is suppressed from the NMJs of mice in which the ColQ gene is inactivated and miniature endplate potentials are not prolonged by AChE inhibition.
37. Li B., Stribley J.A., Ticu A., Xie W., Schopfer L.M., Hammond P., Brimijoin S., Hinrichs S.H., and Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 75 (2000) 1320-1331. Mice are severely handicapped but can live after complete suppression of AChE; there is no compensatory overexpression of BChE, but the presence of this enzyme becomes vital.
38. Nguyen-Huu T., Dobbertin A., Barbier J., Minic J., Duvaldestin P., and Molgó J. Cholinesterases and the resistance of the mouse diaphragm to the effect of tubocurarine. Anesthesiol 103 (2005) 788-795. A physiological study of muscle excitation in wild-type and ColQ-deficient mice; different effects of AChE inhibition. The nerve-evoked response of the rat diaphragm is less sensitive to d-tubocurarine than that of the extensor digitorum longus.
39. Paraoanu L.E., and Layer P.G. Mouse AChE binds in vivo to domain IV of laminin-1beta. Chem Biol Interact 157-158 (2005) 411-413
40. Bon S., Ayon A., Leroy J., and Massoulié J. Trimerization domain of the collagen tail of acetylcholinesterase. Neurochem Res 28 (2003) 523-535
41. Donger C., Krejci E., Pou Serradell A.P., Eymard B., Bon S., Nicole S., Chateau D., Gary F., Fardeau M., Massoulié J., et al. Mutation in the human acetylcholinesterase-associated collagen gene, ColQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (type Ic). Am J Human Genet 63 (1998) 967-975
42. Ohno K., Engel A.G., Brengman J.M., Shen X.M., Heidenreich F., Vincent A., Milone M., Tan E., Demirci M., Walsh P., et al. The spectrum of mutations causing end-plate acetylcholinesterase deficiency. Ann Neurol 47 (2000) 162-170. Description of numerous human mutations in the ColQ gene and their effects.
43. Mihaylova V., Müller J.S., Vilchez J.J., Salih M.A., Kabiraj M.M., D'Amico A., Bertini E., Wölfle J., Schreiner F., Kurlemann G., et al. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes. Brain 131 (2008) 747-759. Clinical studies showing a wide variability in the severity of symptoms caused by ColQ mutations.
44. Belbeoc'h S., Falasca C., Leroy J., Ayon A., Massoulié J., and Bon S. Elements of the C-terminal T peptide of acetylcholinesterase that determine amphiphilicity, homomeric and heteromeric associations, secretion and degradation. Eur J Biochem 271 (2004) 1476-1487
45. Massoulié J., Anselmet A., Bon S., Krejci E., Legay C., Mayat E., Morel N., and Simon S. Diversity and processing of acetylcholinesterase. In: Doctor B.P., Quinn D.M., Rotundo R.L., and Taylor P. (Eds). Structure and Function of Cholinesterases and Related Proteins (1998), Plenum Press, New York 3-24
46. Lee H.H., Choi R.C., Ting A.K., Siow N.L., Jiang J.X., Massoulié J., and Tsim K.W. Transcriptional regulation of acetylcholinesterase-associated collagen ColQ: differential expression in fast and slow twitch muscle fibers is driven by distinct promoters. J Biol Chem 279 (2004) 27098-27107. Different transcriptional regulation of the ColQ1 and ColQ1a transcripts, which are preferentially expressed in slow and fast muscles, respectively.
47. Krejci E., Legay C., Thomine S., Sketelj J., and Massoulié J. Differences in expression of acetylcholinesterase and collagen Q control the distribution and oligomerization of the collagen-tailed forms in fast and slow muscles. J Neurosci 19 (1999) 10672-10679. Existence and distribution of ColQ1 and ColQ1a variants in slow and fast muscles; demonstration that the different proportions of A12, A8 and A4 forms observed in these muscles can be reproduced by expressing different ratios of ColQ and AChE transcripts in Xenopus oocytes.
48. Rotundo R.L., Rossi S.G., and Anglister L. Transplantation of quail collagen-tailed acetylcholinesterase molecules onto the frog neuromuscular synapse. J Cell Biol 136 (1997) 367-374. ColQ-AChE forms of external origin can be specifically attached to frog NMJs.
49. Brandan E., Maldonado M., Garrido J., and Inestrosa N.C. Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans. J Cell Biol 101 (1985) 985-992
50. Rossi S.G., and Rotundo R.L. Transient interactions between collagen-tailed acetylcholinesterase and sulfated proteoglycans prior to immobilization in the extracellular matrix. J Biol Chem 271 (1996) 1979-1987. After their externalization at NMJs, ColQ-AChE forms are first reversibly immobilized, most probably through ionic interactions with HSPs, and later become covalently attached to the BL.
51. Deprez P., Inestrosa N.C., and Krejci E. Two different heparin-binding domains in the triple-helical domain of ColQ, the collagen tail subunit of synaptic acetylcholinesterase. J Biol Chem 278 (2003) 23233-23242. Identification and properties of two distinct heparan-binding sites in the collagenous triple helical region of ColQ.
52. Barat A., Escudero E., and Ramírez G. Heparin and the solubilization of asymmetric acetylcholinesterase. FEBS Lett 195 (1986) 209-214
53. Hand D., Dias D., and Haynes L.W. Stabilization of collagen-tailed acetylcholinesterase in muscle cells through extracellular anchorage by transglutaminase-catalyzed cross-linking. Mol Cell Biochem 204 (2000) 65-76
54. Cartaud A., Strochlic L., Guerra M., Blanchard B., Lambergeon M., Krejci E., Cartaud J., and Legay C. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J Cell Biol 165 (2004) 505-515. ColQ interacts with MuSK through its C-terminal domain.
55. Anglister L., Eichler J., Szabo M., Haesaert B., and Salpeter M.M. 125I-labeled fasciculin 2: a new tool for quantitation of acetylcholinesterase densities at synaptic sites by EM-autoradiography. J Neurosci Methods 81 (1998) 63-71
56. Krejci E., Martinez-Pena y Valenzuela I., Ameziane R., and Akaaboune M. Acetylcholinesterase dynamics at the neuromuscular junction of live animals. J Biol Chem 281 (2006) 10347-10354. AChE was labeled by fluorescent fasciculin in living mouse NMJs and fluorescence was monitored over a week. About half of the labeled AChE was renewed within three days. ColQ-AChE appeared to be internalized with AChRs, in the same vesicles.
57. Martinez-Pena y Valenzuela I., and Akaaboune M. Acetylcholinesterase mobility and stability at the neuromuscular junction of living mice. Mol Biol Cell 18 (2007) 2904-2911. The lateral diffusion of AChE was studied in mice NMJs in vivo, by labeling with fasciculin conjugated with streptavidins of different colors and photo-unbinding. Perijunctional AChE is mobile and can be recruited to the NMJ, where it becomes trapped and immobile. This stability was reduced in the absence of the post-synaptic protein dystrobrevin.
58. Arber S., Burden S.J., and Harris A.J. Patterning of skeletal muscle. Curr Opin Neurobiol 12 (2002) 100-103
59. Liu Y., Padgett D., Takahashi M., Li H., Sayeed A., Teichert R.W., Olivera B.M., McArdle J.J., Green W.N., and Lin W. Essential roles of the acetylcholine receptor gamma-subunit in neuromuscular synaptic patterning. Development 135 (2008) 1957-1967
60. Wilson M.H., and Deschenes M.R. The neuromuscular junction: anatomical features and adaptations to various forms of increased, or decreased neuromuscular activity. Int J Neurosci 115 (2005) 803-828
61. Hughes B.W., Kusner L.L., and Kaminski H.J. Molecular architecture of the neuromuscular junction. Muscle Nerve 33 (2006) 445-461
62. Weinberg C.B., and Hall Z.W. Junctional form of acetylcholinesterase restored at nerve-free endplates. Dev Biol 68 (1979) 631-635. An old observation that deserves to be re-visited and explained in molecular terms: ColQ-AChE disappears from rat NMJs after denervation but re-appear at original endplates, as well as at new endplates, after ectopic re-innervation, demonstrating that the synaptic BL was able to induce their synthesis and accumulation when the muscle was active.
63. Lømo T., Massoulié J., and Vigny M. Stimulation of denervated rat soleus muscle with fast and slow activity patterns induces different expression of acetylcholinesterase molecular forms. J Neurosci 5 (1985) 1180-1187
64. Bacou F., Vigneron P., and Massoulié J. Acetylcholinesterase forms in fast and slow rabbit muscle. Nature 296 (1982) 661-664
65. Couraud J.Y., Di Giamberardino L., Hassig R., and Mira J.C. Axonal transport of the molecular forms of acetylcholinesterase in developing and regenerating peripheral nerve. Exp Neurol 80 (1983) 94-110
66. Camp S., De Jaco A., Zhang L., Marquez M., De la Torre B., and Taylor P. Acetylcholinesterase expression in muscle is specifically controlled by a promoter-selective enhancesome in the first intron. J Neurosci 28 (2008) 2459-2470. Deletion of an intronic region in the AChE gene suppresses its expression in muscle and abolishes the accumulation of ColQ-AChE at NMJs.
67. Nicole S., Davoine C.S., Topaloglu H., Cattolico L., Barral D., Beighton P., Hamida C.B., Hammouda H., Cruaud C., White P.S., et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 26 (2000) 480-483
68. Arikawa-Hirasawa E., Le A.H., Nishino I., Nonaka I., Ho N.C., Francomano C.A., Govindraj P., Hassell J.R., Devaney J.M., Spranger J., et al. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet 70 (2002) 1368-1375
69. Stum M., Girard E., Bangratz M., Bernard V., Herbin M., Vignaud A., Ferry A., Davoine C.S., Echaniz-Laguna A., René F., et al. Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia. Hum Mol Genet 17 (2008) 3166-3179
70. Kimbell L.M., Ohno K., Engel A.G., and Rotundo R.L. C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J Biol Chem 279 (2004) 10997-11005. ColQ-AChE A12 forms containing several mutations of the C-terminal domain of ColQ, identified in human patients, which were produced in vitro, failed to attach to frog NMJs. This domain is therefore required for the attachment of ColQ-AChE in the BL at NMJs, in addition to ionic interactions of ColQ with HSPs.
71. Ito M., Suzuki Y., Okada T., Fukudome T., Yoshimura T., Masuda A., Krejci E., and Ohno K. rAAV8-mediated protein anchoring of asymmetric acetylcholinesterase (AChE) to the synaptic basal lamina at the neuromucular junction (NMJ). ASCB, 48th Annual Meeting. San Francisco (December 13-17, 2008) (2008) Abstract 2138. In ColQ deficient mice, a viral vector allowed the expression of ColQ in leg muscle fibers, and the resulting ColQ-AChE forms were found to migrate and attach at NMJs in front leg muscles.
72. Feng Z., and Ko C.P. Neuronal glia interactions at the vertebrate neuromuscular junction. Curr Opin Pharmacol 7 (2007) 316-324